6533b836fe1ef96bd12a1b74
RESEARCH PRODUCT
Additional file 4 of Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee
Gabriella GiancaneJoost F. SwartElio CastagnolaAndreas H. GrollGerd HorneffHans-iko HuppertzDaniel J. LovellTom WolfsTroels HerlinPavla DolezalovaHelga SannerGordana SusicFlavio SztajnbokDespoina MaritsiTamas ConstantinVeronika VargovaSujata SawhneyMarite RyggSheila K. OliveiraMarco CattaliniFrancesca BovisFrancesca BagnascoAngela PistorioAlberto MartiniNico WulffraatNicolino Rupertosubject
musculoskeletal diseases3. Good healthdescription
Additional file 4 Table 2. Concomitant medications administered at the time of “confirmed OI”. Bio: biologic, mtx: methotrexate; ste: systemic steroids; sDMARDs: synthetic disease modifying antirheumatic drugs; *sDMARDs are intendend other than MTX.
year | journal | country | edition | language |
---|---|---|---|---|
2020-01-01 |